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1. Introduction 
We have suggested that met s -enkephalin and leu s- 
enkephalin [1] may act as neurotransmitters in both 
the central and peripheral nervous ystems [2,3]. The 
aim of this study was to develop aprocedure for 
studying the biogenesis of the enkephalins and to test 
the hypothesis that these peptides are derived from 
larger precursors via ribosomal synthesis and subse- 
quent proteolytic leavage of the precursor protein. 
2. Materials and methods 
2.1. Biological preparations 
For in vivo studies male, albino rats (300-350 g) 
were anaesthetised with ether and 100/~Ci [3H]tyro- 
sine was injected intracisternally in 50 p.l 0.9% sterile 
NaC1 solution over a period of 5 min. The animals 
were allowed to recover consciousness and were killed 
at various times after the injection. 
For in vitro studies 300-500 mg isolated myenteric 
plexus-longitudinal muscle preparation of the guinea- 
pig [4] was suspended in a 3 ml organ bath. This tissue 
was bathed in Krebs solution at 37°C and gassed with 
95% 02 and 5% CO2. The Krebs Ringer bicarbonate 
solution contained 1/ag/ml each of the following 
L-amino acids: Ala, Arg, Asp, Cys, Glu, Gly, His, Leu, 
Ileu, Lys, Met, Phe, Pro, Ser, Thr, Trp and Tyr. The 
corresponding unlabelled amino acid was omitted 
when [3H]Tyr, [3H]Leu or [3SS]Met were added to 
the bathing solution. Two methods of labelling were 
used: 
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(A) Incubation with 10 #Ci labelled amino acid for 
1 h followed by incubation with cold amino acids 
for up to 12 h, 
(B) Incubation with 10/aCi labelled amino acid for 
4 h with fresh solution every hour followed by 
3 h incubation with cold amino acids. 
2.2. Isolation o f  enkephalins 
Tissues were homogenised in ice-cold 0.1 M HCI 
containing 25/~g each of the enkephalins. The enke- 
phalins were recovered from the tissue supematant 
by chromatography on XAD-2 columns [2,3]. The 
dried eluate from the XAD-2 column was dissolved in 
0.1 ml 0.2 M acetic acid and chromatographed (fig.l) 
on a 45 × 0.4 cm cation exchange column of HC- 
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Fig. 1. Chromatography of myenteric plexus extract on HC- 
Pellionex-SCX (45 × 0.4 cm). The column was equilibrated 
with 0.2 M acetic acid containing 30% (v/v) methanol. After 
injection of the tissue xtract the solvent was changed 
immediately to0.35 M ammonium acetate containing 30% 
methanol (v/v) at pH 8.35. Column flow rate = 0.8 ml/min, 
ultraviolet absorption at280 nm, 1 cm light path with 8 ~1 
flow cell and 0.16 AU full scale deflection. 
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Fig.2. Chromatography of enkephalins on AE-PeUionex-SAX 
(100 X 0.4 cm). The column was equilibrated with 0.08 M 
ammonium acetate, pH 9.5 and then the enkephalin fraction 
from the HC-Pellionex-SCX was injected. After 1 min the 
eluent was changed to 0.04 M acetic acid containing 30% 
methanol (v/v). Column flow rate = 1 ml/min, ultraviolet 
absorption at 280 nm as in fig.l. 
3.1. Radiochemical purity 
Individual radioactive bands corresponding to
metS-enkephalin a d leuS-enkephalin were observed 
on t.l.c, of brain and myenteric plexus extracts after 
labelling with [3H]tyrosine (fig.3). Incubation with 
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Pellionex-SCX (Whatman). The enkephalin peak was 
collected and further chromatographed on a 100 × 0.4 
cm anion exchange column of  AE-Pellionex-SAX 
(Whatman) as shown in fig.2. The enkephalin fraction 
was lyophylised, redissolved in 20/al MeOH:H20 
(80:20 v/v) and spotted on a silica gel plate (Merck 
5721). The plate was developed for 10-12 cm with 
ethyl acetate/pyridine/water/acetic acid 
(100:42:25:11). The enkephalins were completely 
resolved in this system (fig.3). The appropriate spots 
were usually located for elution and liquid scintilla- 
tion counting by spraying the whole plate with nin- 
hydr in-cadmium acetate reagent; however, a marker 
lane was used to locate the peptides for elution when 
this procedure was followed by electrophoresis. The 
overall recovery of met- or leu-enkephalin at the thin- 
layer chromatographic (t.l.c.) stage was 10%. 
Electrophoresis atpH 2 was carried out on 20 cm 
lengths of silica gel impregnated glass fibre sheets 
(Gelman Instrument Co.). A constant current of  30 
mA (450-500 V) was applied for 1.5 h. 
2.3. lsotopes 
L- [2,3,5,6-3H] Tyrosine (80 Ci/mmol), L- [4,5-3H] -
leucine (20 Ci/mmol) and L-[3SS]methionine 
(800-1200 Ci/mmol) were purchased from the 
Radiochemical Centre, Amersham. 
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Fig.3. Thin-layer chromatographic separation of enkephalins. 
The peptides were located by ninhydrin, 5mm or 7 mm 
bands of the plate were eluted with 1 ml of methanol/water 
(1:1, v/v) and the radioactivity determined in a liquid scintil- 
lation counter. The patterns of activity were obtained with 
tissues incubated with [~SS]methionine, [3H]tyrosine and 
[3H]leucine for 4 h. The actual cpm less background counts 
(12 cpm) are shown. 
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[3H]leucine resulted in the appearance of radioactivity 
only in the leuS-enkephalin position whilst incubation 
with [aSS]methionine s lectively labelled the material 
corresponding to met s-enkephalin (fig.3). 
The peptides isolated by t.l.c, were adjudged radio- 
chemically homogenous since electrophoresis howed 
that >95% of the radioactivity migrated as one band 
corresponding to the enkephalins. Further, there was 
no change in the specific activity of the t.l.c, peptides 
when subjected to electrophoresis. 
3.2. Rate of incorporation i to rnyenteric plexus 
Incorporation of [3H]tyrosine into the two 
enkephalins showed two distinct phases (fig.4). There 
was an initial lag phase of 1 -2  h after which incorpora- 
tion followed a linear time course for up to 12 h. The 
rate of incorporation i to metS-enkephalin was much 
faster than that for leu s-enkephalin and this may 
correlate with our observation [2,3] that there is a 
three-times greater concentration f metS-enkephalin 
in this tissue than leu s -enkephalin. 
3.3. Effect of inhibiting protein synthesis 
Puromycin (0.1 mM) and cyclohexamide (0.1 mM) 
caused a significant inhibition of [aH]tyrosine incor- 
poration into tissue protein and the enkephalins 
(table 1). These effects did not appear to be of a 
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Fig.4. Time course of [aH] tyrosine incorporation i to 
enkephalins of the myenteric plexus. The tissues were 
labelled by incubation with 10 pCi tyrosine for 1 h followed 
by incubation with cold amino acids for up to 12 h (method 
A). Linear egression analysis was carried out on the 2-12 
h points, this gave correlation coefficients of 0.999 and 
0.987 and slopes of 60.3 and 12.8 for metS-enkephalin and 
leuS-enkephalin, respectively. No correction has been made 
for the recovery of the peptides which averaged 10%. 
Table 1 
Effect of puromycin and cycloheximide on [SH]tyrosine incorporation i to the myenteric plexus 
[ 3HI Tyrosine incorporated into: 
Met s -enkephalin Leu s -enkephalin Protein 
(dpm.g -1) (dpm.g -1) (dpm × 10-~)~g -1 
(A) Control 3752 ± 240 1424 ± 64 24.6 ± 2.4 
Puromycin 312 ± 56 296 ± 128 1.5 ± 0.3 
(B) Control 2888 -+ 312 1436 ± 192 20.2 ± 2.7 
Cycloheximide 544 ± 160 197 ± 72 2.1 ± 0.1 
(C) Control 1360 ± 188 740 ± 132 18.7 ± 1.4 
Puromycin 1312 ± 160 560 ± 48 14.8 ± 1.3 
Paired experiments with 3 tissues/group. In (A) and (B) the tissues were incubated for 4 h with a total 
of 80 pCi [3H]tyrosine followed by 2 h without label; puromycin and cycloheximide (0.1 mM each) 
were present throughout the expt. In (C) the tissues were incubated for 2 h with a total of 40/~Ci of 
[aH]tyrosine and then for a further 4 h in the presence of puromycin (0.1 mM) or just with cold amino 
acids (control). The incorporation of [ 3H]tyrosine into protein was determined after 5% trichloro- 
acetic acid precipitation of the original tissue pellet 
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Table 2 
[ 3Hi Tyrosine incorporation i to rat brain enkephalins 
December 1977 
Hours 
after Met s -enkephalin 
injection (n) (dpm.g -~ ) 
Leu s -enkephalin 
(dpm.g -1 
Protein 
(dpm × 10-6).g -1 
1 (2) 54 12 3.45 
2 (5) 53 ± 18 13 ± 3.5 3.90 ± 0.47 
4 (7) 57 ± 13 22 ± 5 1.73 ± 0.65 
8 (6) 49-+ 10 18-+ 5 3.26 ± 0.33 
16 (3) 55 -+ 16 15 ± 5 3.14 -+ 0.42 
32 (3) 38 ± 16 13 ± 5 1.72 ± 0.39 
48 (4) 45± 8 20±2 2.95± 0.37 
96 (3) 28± 1 13±2 2.03±0.10 
Rats were injected intracisternally with 50 ~aCi [3H]tyrosine as m Materials and methods. The 
incorporation i to protein was determined after 5% trichloroacetic a id precipitation. The 
incorporation i to enkephalin snot corrected for recovery (mean = 10%). n = number of experi- 
ments. Means and standard errors are shown for each time point except 1 h where only the mean 
is shown 
general neurotoxic nature since addition of puromycin 
after incubation with [aH]tyrosine did not affect the 
subsequent appearance of labelled enkephalins (table 
2) and nerve-induced contractions of the myenteric 
plexus were unaffected by these concentrations of 
cyclohexamide and puromycin. 
The isolated myenteric plexus preparation is likely 
to prove an excellent system for studying enkephalin- 
ergic mechanisms. Our results are compatible with 
the hypothesis that the enkephalins are derived from 
ribosomally synthesized protein precursors. We also 
conclude that stores of both met s- and leuS-enkephalin 
in the myenteric plexus are produced locally and are 
not derived from pituitary or brain endorphins. 
3.4. Incorporation into rat brain enkephalins 
Preliminary experiments with intracisternally 
administered [3H] tyrosine showed incorporation of
labelled tyrosine into both enkephalins (table 2). The 
degree of labelling was small and rather variable; 
however, the time course was consistent with the 
labelling of a precursor store that turns over rather 
slowly. Attempts are now being made to refine this 
approach so as to allow a more accurate assessment of
the biogenesis and turnover of enkephalin i  vivo; 
these estimations should greatly aid our understanding 
of the physiological roles of these peptides. 
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